0002119031-26-000002.txt : 20260316 0002119031-26-000002.hdr.sgml : 20260316 20260313175504 ACCESSION NUMBER: 0002119031-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260316 DATE AS OF CHANGE: 20260313 EFFECTIVENESS DATE: 20260316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurophos Inc. CENTRAL INDEX KEY: 0002119031 ORGANIZATION NAME: EIN: 844962810 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576538 FILM NUMBER: 26753736 BUSINESS ADDRESS: STREET 1: 4120 FREIDRICH LN STREET 2: SUITE 600 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 737-367-5551 MAIL ADDRESS: STREET 1: 4120 FREIDRICH LN STREET 2: SUITE 600 CITY: AUSTIN STATE: TX ZIP: 78744 D 1 primary_doc.xml X0708 D LIVE 0002119031 Neurophos Inc. 4120 FREIDRICH LANE SUITE 600 AUSTIN TX TEXAS 78744 737.367.5551 DELAWARE None None Corporation true Patrick Bowen 4120 Freidrich Lane Suite 600 Austin TX TEXAS 78744 Executive Officer Director Christopher Alliegro 4120 Freidrich Lane Suite 600 Austin TX TEXAS 78744 Director Nathan Kundtz 4120 Freidrich Lane Suite 600 Austin TX TEXAS 78744 Director Preston Woo 4120 Freidrich Lane Suite 600 Austin TX TEXAS 78744 Executive Officer Hod Finkelstein 4120 Freidrich Lane Suite 600 Austin TX TEXAS 78744 Executive Officer Other Technology Decline to Disclose 06b false 2025-11-26 false true true false 0 109171214 109171214 0 Preferred Stock and Common Stock issuable upon conversion thereof. Total Offering Amount and Total Amount Sold include conversion of the previously issued convertible securities. false 44 0 0 0 false Neurophos Inc. /s/ Patrick Bowen Patrick Bowen Chief Executive Officer 2026-03-13